Tuesday, October 4, 2022


Biotechnology News Magazine

H.E.L Group Expands Operations in India

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the expansion of its operations in India, with an increased focus on high growth areas of biotech and battery testing industries. The move will see the creation of a wholly-owned subsidiary, H.E.L India, which will provide direct sales and marketing, service, and support operations to customers in India from February 2022.

To support India’s growing biotech and pharmaceutical markets, H.E.L will create a dedicated regional hub to provide in-country support directly to customers. Until now, services in India have been successfully operated through a longstanding distributor partnership with Skytech Systems, one of India’s leading analytical instrument distribution companies. H.E.L will continue to work with Skytech to fully transition operations over the next twelve months with the current team of experienced service and support engineers transferring into the new subsidiary to ensure continuity for existing customers.

Supporting the move, the Company will be making several key appointments, including recruiting an experienced General Manager to build the regional team, alongside specialist product area capabilities.

Louise Madden, CEO of H.E.L Group, commented: “We are excited to be opening a full H.E.L subsidiary in India as part of our plans to have the right sales and support approach across the globe. India is a significant, growing market, and now is the right time for us to establish a direct presence. This brings our mission of creating a healthier, sustainable and safer environment for everyone a step closer. We sincerely thank our current partner Skytech for their help over the last two decades in developing and growing our business in the region.”

Chandrahas Shetty, CEO of Skytech Systems, added: “India has seen exponential growth across many scientific markets, and we are pleased to have worked alongside H.E.L for more than 20 years to help provide solutions to our customers’ problems. We are looking forward to continuing to work together in the immediate term to ensure a smooth transition for our two businesses and our joint customers, and we are sure that H.E.L will continue to enjoy success in the Indian market.”

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine